Ticker: SBTX

Company: Silverback Therapeutics, Inc.

Person: Richard E Lowenthal, director, officer, owns ten percent - or more - of the company

Transaction date: Dec. 6, 2024

Reporting date: Dec. 9, 2024

Average share price: 5.8562105431395

Bought 37541.0 shares for 219848.0